文献速递胸部肿瘤

CD8+记忆与旁观者T细胞对非小细胞肺癌预后的影响

[The impact of CD8+ memory and bystander T cells on the prognosis of non-small cell lung cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2026-01-01

该回顾性研究纳入256例根治术后ⅠA~ⅢB期NSCLC患者,用多重免疫荧光检测肿瘤中心(TC)和侵袭边缘(IM)的CD8+组织驻留记忆T细胞(TRM)和旁观者T细胞(Tbys)密度。中位随访37.9个月,复发87例(34.0%)。全部患者中这些亚群与RFS无关,但仅在172例N0患者中,TC区域高TRM/CD8+和TRM/Tbys是复发独立危险因素,高Tbys/CD8+是独立保护因素。

要点

  • 全部256例NSCLC中,TC和IM区域CD8+亚群与RFS均无关(均P>0.05)。
  • N0患者中,高TC TRM/CD8+(HR=2.772)和高TC TRM/Tbys(HR=2.656)是复发独立危险因素。
  • N0患者中,高TC Tbys/CD8+是复发独立保护因素(HR=0.324)。

核心结论

  • NSCLC原发灶TC区域特定CD8+ T细胞亚群仅与N0期患者根治术后复发相关。
  • TC区域TRM/CD8+和TRM/Tbys越高、Tbys/CD8+越低,N0患者复发风险越高。

研究设计与样本

  • 回顾性收集2014年1月1日至2018年12月31日山东省肿瘤医院根治性手术的ⅠA~ⅢB期NSCLC患者256例。
  • 制备含TC和IM区域的组织芯片,多重免疫荧光染色检测CD8+ T细胞、TRM和Tbys密度。
  • 采用Kaplan-Meier法和Cox比例风险模型分析复发影响因素。

主要发现

  • TC区域TRM/CD8+为34.3%、Tbys/CD8+为67.9%、TRM/Tbys为50.5%;IM区域分别为29.6%、70.7%、41.9%。
  • 中位随访37.9个月,复发87例(34.0%)。
  • 全部256例中,IM和TC区域各亚群与RFS均无关(均P>0.05)。
  • 172例N0患者中,IM区域高Tbys/CD8+组RFS率高于低组(P=0.050)。
  • N0患者中,TC区域高TRM/CD8+和TRM/Tbys组RFS率低于低组(均P<0.05),高Tbys/CD8+组RFS率高于低组(P=0.005)。

关键数值与推荐

  • N0患者多因素Cox:高TC TRM/CD8+为复发独立危险因素(HR=2.772,95% CI:1.260~6.098)。
  • N0患者多因素Cox:高TC TRM/Tbys为复发独立危险因素(HR=2.656,95% CI:1.205~5.855)。
  • N0患者多因素Cox:高TC Tbys/CD8+为复发独立保护因素(HR=0.324,95% CI:0.147~0.711)。

临床怎么用

  • 对N0期NSCLC根治术后患者,可检测TC区域TRM/CD8+、TRM/Tbys和Tbys/CD8+以辅助复发风险分层。
  • TC区域高TRM/CD8+、高TRM/Tbys或低Tbys/CD8+的N0患者可能需更密切随访或强化治疗策略。

局限性

  • 本研究为单中心回顾性研究,样本量256例。
  • 仅在N0患者中观察到CD8+亚群与RFS的关联,N1~2患者中未观察到关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: To investigate the relationship between CD8+ tissue-resident memory T cells (TRM) and CD8+ bystander T cells (Tbys) in the tumor center (TC) and invasive margin (IM) regions of primary non-small cell lung cancer (NSCLC) and recurrence, and to perform stratified analysis based on lymph node status to guide individualized treatment. Methods: A retrospective review was conducted of patients with stage IA-IIIB non-small cell lung cancer (NSCLC) who underwent radical surgery at Shandong Provincial Cancer Hospital between January 1, 2014 and December 31, 2018. Tissue microarrays containing TC and IM regions were prepared, and multicolor immunofluorescence staining was applied to quantify the density of CD8+ T cells (CK- CD8+), tissue-resident memory T cells (CK- CD103+ CD8+), and bystander T cells (CK- CD103- CD8+). Kaplan-Meier and Cox proportional hazards models were used to identify factors associated with recurrence. Results: In the TC region, TRM/CD8+ T cells, Tbys/CD8+ T cells, and TRM/Tbys accounted for 34.3%, 67.9%, and 50.5% of CD8+ T cells, respectively. In the IM region, TRM/CD8+ T cells accounted for 29.6%, Tbys/CD8+ T cells for 70.7%, and TRM/Tbys for 41.9%. At a median follow-up of 37.9 months, recurrence occurred in 87 patients (34.0%). In all 256 patients, TRM/CD8+ T cells, Tbys/CD8+ T cells, and TRM/Tbys in both IM and TC regions were unrelated to RFS (all P>0.05). Among the 172 N0 patients, the high Tbys/CD8+ T cell group in the IM region showed higher RFS rates than the low group (P=0.050), while the high-level groups for TRM/CD8+ T cells and TRM/Tbys in the TC region showed lower RFS rates than their low-level counterparts (all P<0.05). Conversely, the high-level group for Tbys/CD8+ T cells in the TC region demonstrated a higher RFS rate than the low-level group (P=0.005). Multivariate Cox analysis revealed that high TC TRM/CD8+ T cells and high TC TRM/Tbys were independent risk factors for postoperative recurrence in N0 NSCLC patients (HR=2.772, 95% CI: 1.260-6.098; HR=2.656, 95% CI: 1.205-5.855), while high TC Tbys/CD8+ T cells was an independent protective factor for postoperative recurrence in N0 NSCLC patients (HR=0.324, 95% CI: 0.147-0.711). Among the 84 N1-2 patients, TRM/CD8+ T cells, Tbys/CD8+ T cells, and TRM/Tbys in the IM and TC regions were not associated with RFS (all P>0.05). Conclusions: Specific CD8+ T cell subsets in the TC region of the primary tumor in NSCLC patients are associated only with recurrence after curative surgery in N0 patients. Elevated TRM/CD8+ T and TRM/Tbys ratios, coupled with reduced Tbys/CD8+ T ratios, correlate with heightened recurrence risk. This may aid in stratifying the risk of recurrence in N0 patients after surgery and guide treatment strategies. 目的: 探讨非小细胞肺癌(NSCLC)原发灶肿瘤中心(TC)和侵袭边缘(IM)区域CD8+组织驻留记忆T细胞(TRM)和CD8+旁观者T细胞(Tbys)与复发的关系,以指导NSCLC的个体化治疗。 方法: 回顾性收集2014年1月1日至2018年12月31日在山东省肿瘤医院接受根治性手术治疗的ⅠA~ⅢB期NSCLC患者256例。制备包含TC和IM区域的组织芯片,通过多重免疫荧光染色检测CD8+ T细胞(CK- CD8+)、TRM(CK- CD103+ CD8+)和Tbys(CK- CD103- CD8+)的密度。生存分析采用Kaplan-Meier法,采用Cox比例风险模型明确复发影响因素。 结果: 在TC区域,TRM/CD8+ T细胞为34.3%,Tbys/CD8+ T细胞为67.9%,TRM/Tbys为50.5%。在IM区域,TRM/CD8+ T细胞为29.6%,Tbys/CD8+ T细胞为70.7%,TRM/Tbys为41.9%。中位随访37.9个月,复发87例(34.0%)。在全部256例患者中,IM和TC区域的TRM/CD8+ T细胞、Tbys/CD8+ T细胞及TRM/Tbys均与无复发生存时间(RFS)无关(均P>0.05)。在172例N0期患者中,IM区域的Tbys/CD8+ T细胞高组RFS率高于低组(P=0.050),TC区域的TRM/CD8+ T细胞和TRM/Tbys高组、RFS率低于相应低组(均P<0.05),TC区域的Tbys/CD8+ T细胞高组的RFS率高于低组(P=0.005)。多因素Cox分析显示,高TC TRM/CD8+ T细胞和高TC TRM/Tbys是N0期NSCLC患者术后复发的独立危险因素(HR=2.772,95% CI:1.260~6.098;HR=2.656,95% CI:1.205~5.855),高TC Tbys/CD8+ T细胞是N0期NSCLC患者术后复发的独立保护因素(HR=0.324,95% CI:0.147~0.711)。在84例N1~2期患者中,IM和TC区域的TRM/CD8+ T细胞、Tbys/CD8+ T细胞及TRM/Tbys均与RFS无关(均P>0.05)。 结论: NSCLC患者原发灶TC区域中特定CD8+ T细胞亚群仅与N0期患者根治术后复发有关,TC区域TRM/CD8+ T细胞和TRM/Tbys越高、Tbys/CD8+ T细胞越低越易复发。这可能有助于N0期NSCLC患者术后复发风险分层并指导治疗。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen QH, Cao FH, Yang LY, et al. [The impact of CD8+ memory and bystander T cells on the prognosis of non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2026. PMID: 42595552. doi:10.3760/cma.j.cn112152-20250709-00331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。